
<style>
    * {
        box-sizing: border-box !important;
    }

    body {
        font-family: 'Inter', 'Segoe UI', Roboto, 'Helvetica Neue', Arial, sans-serif !important;
        line-height: 1.9 !important;
        color: #1f1f1f !important;
        max-width: none !important;
        margin: 0 !important;
        padding: 8px 16px 16px 16px !important;
        background: #ffffff !important;
        font-size: 16.5px !important;
    }

    p {
        margin-bottom: 20px !important;
        font-size: 16.5px !important;
        line-height: 1.95 !important;
        color: #1f1f1f !important;
        font-weight: 400 !important;
    }

    strong, b {
        color: #1a73e8 !important;
        font-weight: 700 !important;
        background: rgba(26, 115, 232, 0.08) !important;
        padding: 2px 6px !important;
        border-radius: 8px !important;
    }

    /* Details/Summary (collapsible sections) */
    details {
        background: linear-gradient(135deg, #f8f9fa 0%, #ffffff 100%) !important;
        border-radius: 8px !important;
        padding: 24px 28px !important;
        margin: 24px 0 !important;
        border: none;
        box-shadow: none !important;
        transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1) !important;
    }

    details:hover {
        border-color: #1a73e8 !important;
        box-shadow: none !important;
        transform: translateY(-2px) !important;
    }

    details[open] {
        background: #ffffff !important;
        border-color: #1a73e8 !important;
        box-shadow: none !important;
    }

    summary {
        cursor: pointer !important;
        font-weight: 800 !important;
        color: #ffffff !important;
        font-size: 20px !important;
        padding: 16px 24px !important;
        border-radius: 8px !important;
        background: linear-gradient(135deg, #1a73e8 0%, #1557b0 100%) !important;
        transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1) !important;
        display: flex !important;
        align-items: center !important;
        user-select: none !important;
        box-shadow: none !important;
        letter-spacing: 0.5px !important;
    }

    summary:hover {
        background: linear-gradient(135deg, #1557b0 0%, #0d47a1 100%) !important;
        transform: translateX(6px) scale(1.02) !important;
        box-shadow: none !important;
    }

    summary:active {
        transform: translateX(4px) scale(0.99) !important;
    }

    summary::marker {
        color: rgba(255, 255, 255, 0.9) !important;
        font-size: 1.3em !important;
    }

    summary strong {
        background: rgba(255, 255, 255, 0.2) !important;
        color: #ffffff !important;
        padding: 4px 12px !important;
        border-radius: 8px !important;
        margin-left: 8px !important;
        font-size: 19px !important;
        letter-spacing: 1px !important;
    }

    /* Tables - Premium Design */
    table {
        width: 100% !important;
        border-collapse: separate !important;
        border-spacing: 0 !important;
        margin: 28px 0 !important;
        border-radius: 8px !important;
        overflow: hidden !important;
        box-shadow: none !important;
        border: none !important;
        background: #ffffff !important;
    }

    table.simple-table {
        background: linear-gradient(135deg, #ffffff 0%, #f8f9fa 100%) !important;
    }

    table tr {
        transition: all 0.25s cubic-bezier(0.4, 0, 0.2, 1) !important;
        position: relative !important;
    }

    table tr:nth-child(odd) {
        background: rgba(248, 249, 250, 0.5) !important;
    }

    table tr:nth-child(even) {
        background: rgba(255, 255, 255, 0.8) !important;
    }

    table tr:hover {
        background: linear-gradient(90deg, #e8f0fe 0%, #f1f8ff 100%) !important;
        transform: translateX(4px) scale(1.01) !important;
        box-shadow: none !important;
        z-index: 1 !important;
    }

    table td {
        padding: 18px 24px !important;
        border-bottom: 1px solid rgba(232, 234, 237, 0.6) !important;
        font-size: 16.5px !important;
        line-height: 1.7 !important;
        color: #1f1f1f !important;
        vertical-align: middle !important;
    }

    table tr:last-child td {
        border-bottom: none !important;
    }

    /* First column (A, B, C, D, E) */
    table td:first-child {
        font-weight: 800 !important;
        color: #ffffff !important;
        width: 52px !important;
        text-align: center !important;
        font-size: 18px !important;
        background: linear-gradient(135deg, #1a73e8 0%, #1557b0 100%) !important;
        border-right: 3px solid #1557b0 !important;
        position: relative !important;
        letter-spacing: 0.5px !important;
    }

    table tr:hover td:first-child {
        background: linear-gradient(135deg, #1557b0 0%, #0d47a1 100%) !important;
        box-shadow: none !important;
    }

    /* Second column (content) */
    table td:nth-child(2) {
        font-weight: 500 !important;
        padding-left: 28px !important;
    }

    /* Third column (empty - hide it) */
    table td:last-child:empty {
        display: none !important;
    }

    /* Lists */
    ul, ol {
        margin: 16px 0 !important;
        padding-left: 32px !important;
    }

    li {
        margin: 10px 0 !important;
        line-height: 1.8 !important;
        color: #1f1f1f !important;
    }

    ul.bulleted-list li {
        position: relative !important;
        padding-left: 8px !important;
    }

    ul.toggle {
        list-style: none !important;
        padding-left: 0 !important;
    }

    /* Links */
    a {
        color: #1a73e8 !important;
        text-decoration: none !important;
        font-weight: 600 !important;
        border-bottom: 2px solid transparent !important;
        transition: all 0.2s !important;
    }

    a:hover {
        border-bottom-color: #1a73e8 !important;
        background: rgba(26,115,232,0.08) !important;
        padding: 2px 4px !important;
        border-radius: 8px !important;
    }

    /* Images & Media */
    img, video {
        max-width: none !important;
        height: auto !important;
        border-radius: 8px !important;
        box-shadow: none !important;
        margin: 24px 0 !important;
        display: block !important;
        border: none !important;
    }

    img:hover, video:hover {
        box-shadow: none !important;
        border-color: #1a73e8 !important;
    }

    /* Code blocks (if any) */
    code {
        background: #f1f3f4 !important;
        padding: 2px 8px !important;
        border-radius: 8px !important;
        font-family: 'Courier New', monospace !important;
        font-size: 14px !important;
        color: #d93025 !important;
    }

    pre {
        background: #f8f9fa !important;
        padding: 8px 16px 16px 16px !important;
        border-radius: 8px !important;
        overflow-x: auto !important;
        border-left: 4px solid #1a73e8 !important;
    }

    /* Headings */
    h1, h2, h3, h4, h5, h6 {
        color: #1a73e8 !important;
        font-weight: 700 !important;
        margin-top: 24px !important;
        margin-bottom: 16px !important;
        line-height: 1.4 !important;
    }

    h1 { font-size: 32px !important; }
    h2 { font-size: 26px !important; }
    h3 { font-size: 22px !important; }
    h4 { font-size: 19px !important; }

    /* Blockquotes */
    blockquote {
        border-left: 4px solid #1a73e8 !important;
        padding-left: 20px !important;
        margin: 20px 0 !important;
        font-style: italic !important;
        color: #5f6368 !important;
        background: #f8f9fa !important;
        padding: 16px 20px !important;
        border-radius: 8px !important;
    }

    /* Horizontal Rule */
    hr {
        border: none !important;
        height: 2px !important;
        background: linear-gradient(to right, transparent, #1a73e8, transparent) !important;
        margin: 32px 0 !important;
    }

    /* Selection */
    ::selection {
        background: #e8f0fe !important;
        color: #1a73e8 !important;
    }

    /* Highlighter styles */
    .highlighted {
        background-color: #ffeb3b !important;
        transition: background-color 0.2s ease !important;
    }

    .highlighter-btn {
        background: none !important;
        border: none !important;
        cursor: pointer !important;
        font-size: 20px !important;
        padding: 0 8px !important;
        margin-left: 8px !important;
        transition: transform 0.2s ease !important;
        vertical-align: middle !important;
    }

    .highlighter-btn:hover {
        transform: scale(1.2) !important;
    }

    .highlighter-btn.active {
        transform: scale(1.1) !important;
        filter: brightness(1.2) !important;
    }

    .highlighter-mode-active {
        cursor: text !important;
    }


    /* Right padding to avoid overlap with sidebar buttons */
    body {
        padding-right: 50px !important;
    }

    @media (max-width: 768px) {
        body {
            padding-right: 16px !important;
        }
    }

</style>




<details open>
<summary><strong>641</strong><button class="bionic-reading-btn" onclick="toggleBionicReading(event)" title="Toggle Bionic Reading (Ctrl+B)"><span id="bionicIcon">üëÅÔ∏è</span></button><button class="highlighter-btn" onclick="toggleHighlighter(event)" title="Toggle Highlighter (Ctrl+H)"><span id="highlighterIcon">üñäÔ∏è</span></button></summary>
<p class="" id="650c36c2-4d93-4b8a-b9e6-ae6c55b7522d">A group of researchers is
                                        developing new drugs for osteoporosis.  They are testing a new drug, Substance
                                        X, that exhibits the following metabolic effects when given via an infusion in
                                        varying doses (as shown in the graphs below).</p>
<figure class="image" id="8203f706-238f-4cce-99d7-a1a47cdc0d9b"><a href="https://lh7-us.googleusercontent.com/7C4ho0G1gLTpC-EcZr_RoVoetxr0QMsdzdepnxKQDfc6TA38PBqI6h-xFynZ0ewEcEbU07xmU96_IZKxVM5ZXgYGgfxkEz-rqgvA8A1HnnwoIY6C4Dnq10-uU05wmJfC-8CArmltOTjhX2Lw3QqX40Q"><img loading="lazy" src="https://lh7-us.googleusercontent.com/7C4ho0G1gLTpC-EcZr_RoVoetxr0QMsdzdepnxKQDfc6TA38PBqI6h-xFynZ0ewEcEbU07xmU96_IZKxVM5ZXgYGgfxkEz-rqgvA8A1HnnwoIY6C4Dnq10-uU05wmJfC-8CArmltOTjhX2Lw3QqX40Q" style="width:500px"/></a>
</figure>
<p class="" id="4c922bc5-2daf-4603-83a6-9115dc4b9d5d">Which of the following most
                                        closely resembles the metabolic effects of Substance X?</p>
<table class="simple-table" id="a3f13dda-ecd2-4f01-9519-cb2ace93fc5e">
<tbody>
<tr id="5218b5f9-1f76-484e-94e1-1be930999fcc">
<td class="" id=":xDw">A.</td>
<td class="" id="b_N@">1,25-dihydroxyvitamin D analog</td>
<td class="" id="adik"></td>
</tr>
<tr id="6ca2cf67-87e7-4c76-be81-26ca4785a14a">
<td class="" id=":xDw">B.</td>
<td class="" id="b_N@">Fibroblast growth factor 23 inhibitor</td>
<td class="" id="adik"></td>
</tr>
<tr id="5b4eec75-50ca-4542-ad3b-97f165d8bd62">
<td class="" id=":xDw">C.</td>
<td class="" id="b_N@">Pyrophosphate analog</td>
<td class="" id="adik"></td>
</tr>
<tr id="f3b8dad1-b942-4091-acb8-ef4c5cdefa41">
<td class="" id=":xDw">D.</td>
<td class="" id="b_N@">Receptor activator of nuclear factor kappa-B
                                                    ligand (RANK-L) inhibitor</td>
<td class="" id="adik"></td>
</tr>
<tr id="3803b6fb-f50b-42c3-9745-0559ebafcd92">
<td class="" id=":xDw">E.</td>
<td class="" id="b_N@">Recombinant parathyroid hormone</td>
<td class="" id="adik"></td>
</tr>
</tbody>
</table>
<ul class="toggle" id="6c893c92-7dea-4c7f-9155-a4dd157a2b40">
<li>
<details>
<summary>Submit</summary>
<table class="simple-table" id="7d114f74-b7d3-49a9-b4b7-5ea4e57fa5eb">
<tbody>
<tr id="d83388ec-a4cb-4f0d-96f6-91909f8f98cb">
<td class="" id="\}TN">A.</td>
<td class="" id="otMe">1,25-dihydroxyvitamin D analog (14%)
                                                            </td>
<td class="" id="FQ;D"></td>
</tr>
<tr id="9af941e7-5739-464e-8c13-fdb5fac12bd2">
<td class="" id="\}TN">B.</td>
<td class="" id="otMe">Fibroblast growth factor 23 inhibitor
                                                                (2%)</td>
<td class="" id="FQ;D"></td>
</tr>
<tr id="f885ee0e-0298-4c22-a59b-8e37ffd5306a">
<td class="" id="\}TN">C.</td>
<td class="" id="otMe">Pyrophosphate analog (1%)</td>
<td class="" id="FQ;D"></td>
</tr>
<tr id="acbc2e97-5323-46e2-a507-8e91bee82a95">
<td class="" id="\}TN">D.</td>
<td class="" id="otMe">Receptor activator of nuclear factor
                                                                kappa-B ligand (RANK-L) inhibitor (3%)</td>
<td class="" id="FQ;D"></td>
</tr>
<tr id="2000c759-164b-41a3-852d-8b1e185ff445">
<td class="" id="\}TN">E.</td>
<td class="" id="otMe">Recombinant parathyroid hormone (78%)
                                                            </td>
<td class="" id="FQ;D"></td>
</tr>
</tbody>
</table>
<p class="" id="9aeb75e1-4bcc-43e4-9df6-abb5afe5951f">Incorrect</p>
<p class="" id="9bd12c18-9b8a-4f17-ba99-cf4f9b184e6e">Correct answer E
                                                </p>
<p class="" id="97145612-8aa9-4451-bc4e-cb7bf02d9471">78%Answered
                                                    correctly</p>
<p class="" id="7eafc223-7f77-4322-83a0-37cd643dde31">19 secsTime Spent
                                                </p>
<p class="" id="b71fd448-4091-4ca4-9c23-a8c23caa2d65">2024Version</p>
<ul class="bulleted-list" id="d2a675ba-e427-4e14-abbc-748fbe11035c">
<li style="list-style-type:disc">Explanation</li>
</ul>
<ul class="bulleted-list" id="05c7ef86-2ea4-4857-89ce-01c53d792276">
<li style="list-style-type:disc"></li>
</ul>
<figure class="image" id="b8a70861-84c7-481e-b77b-6ad374c2a05e"><a href="https://lh7-us.googleusercontent.com/0y50HTRxGq74R83QpXMfpXmiYTvHUcWIYRzP5jtVYqoQhh5_sDanZx1XB2L2dK3wDvIo0a_X473zReWFMESuPhTXcgCdHCOaU3ALh5uDbvVxD0FfJt4d-o7YJnwzmlDfLn3cYczYRmFGpGB4H793JJ8"><img loading="lazy" src="https://lh7-us.googleusercontent.com/0y50HTRxGq74R83QpXMfpXmiYTvHUcWIYRzP5jtVYqoQhh5_sDanZx1XB2L2dK3wDvIo0a_X473zReWFMESuPhTXcgCdHCOaU3ALh5uDbvVxD0FfJt4d-o7YJnwzmlDfLn3cYczYRmFGpGB4H793JJ8" style="width:600px"/></a>
</figure>
<p class="" id="0539c5c9-71fe-4c12-b73f-3ea96255e616">This
                                                    investigational drug causes a dose-dependent increase in serum
                                                    calcium and urine phosphate excretion, which resembles the activity
                                                    of parathyroid hormone (PTH).</p>
<p class="" id="f7a8c682-e91f-4da2-ab41-40010681116b">PTH receptors are
                                                    located on osteoblasts (not osteoclasts), and activation causes
                                                    osteoblasts to increase production of receptor activator of nuclear
                                                    factor kappa-B ligand (RANK-L) and monocyte colony-stimulating
                                                    factor.  These factors stimulate osteoclastic precursors to
                                                    differentiate into bone-resorbing osteoclasts.  PTH also decreases
                                                    the release of osteoprotegerin (OPG), a decoy receptor for RANK-L;
                                                    therefore, lower levels of OPG allow for more interaction between
                                                    RANK-L and the osteoclastic receptor, increasing bone resorption and
                                                    releasing calcium and phosphate into circulation.  In the kidney,
                                                    PTH decreases tubular reabsorption of phosphorus while increasing
                                                    reabsorption of calcium.  Therefore, the combined effects are
                                                    increased serum calcium and urine phosphate levels.</p>
<p class="" id="976ba45a-0878-4c9f-a7d8-fa579c43c487">Chronically high
                                                    levels of PTH (ie, hyperparathyroidism) increase the risk of
                                                    osteoporosis.  However, intermittent administration of recombinant
                                                    PTH analogs induces a greater increase in osteoblast activity in
                                                    proportion to osteoclast activity and a net increase in new bone
                                                    formation.  Teriparatide is a recombinant PTH analog used to treat
                                                    osteoporosis.</p>
<p class="" id="07638c05-9da3-48d6-a51c-6ee49f0e79c1">(Choice A)  PTH
                                                    increases renal conversion of 25-hydroxyvitamin D to
                                                    1,25-dihydroxyvitamin D, which increases intestinal absorption of
                                                    calcium and phosphate and decreases PTH secretion via negative
                                                    feedback.  1,25-dihydroxyvitamin D analogs (eg, calcipotriol) can
                                                    raise serum calcium to some extent, but suppression of PTH limits
                                                    the degree of phosphate excretion in the urine.</p>
<p class="" id="8b26addd-b2ac-41b8-b18e-3e13412ff264">(Choice B)  PTH
                                                    increases renal phosphate excretion by inducing internalization and
                                                    destruction of type IIa sodium/phosphate cotransporters (NPT2) in
                                                    the proximal renal tubule.  Fibroblast growth factor 23 (FGF23) is a
                                                    hormone produced by osteocytes that acts synergistically with PTH to
                                                    increase phosphate excretion by downregulating NPT2 gene
                                                    expression.  Investigational FGF23 inhibitors reduce renal phosphate
                                                    excretion.</p>
<p class="" id="c6c408f8-6d69-4ad7-b344-809ff327898c">(Choices C and D) 
                                                    Bisphosphonates (eg, alendronate, risedronate) are pyrophosphate
                                                    analogs that attach to hydroxyapatite binding sites on bone surfaces
                                                    and inhibit osteoclast-mediated bone resorption.  Denosumab is a
                                                    monoclonal antibody that decreases bone resorption by binding to
                                                    RANK-L and blocking the interaction between RANK-L and RANK on
                                                    osteoclast surfaces.  These agents generally lower, rather than
                                                    raise, serum calcium levels.</p>
<p class="" id="67a525b7-54b2-4590-b66e-26c6f1529a75">Educational
                                                    objective:</p>
<p class="" id="9cb0c80a-2504-40a0-97b3-2d0990a02530">Parathyroid
                                                    hormone (PTH) causes increased bone resorption, increased serum
                                                    calcium levels, and increased renal phosphate excretion. 
                                                    Chronically high levels of PTH increase the risk of osteoporosis. 
                                                    However, intermittent administration of recombinant PTH analogs (eg,
                                                    teriparatide) induces a greater increase in osteoblast activity in
                                                    proportion to osteoclast activity and a net increase in bone
                                                    formation.</p>
<p class="" id="775f5e2e-2efd-453a-97c0-ade9fab42be5">Physiology</p>
<p class="" id="b629dee1-617b-48e0-a503-276f834fef7f">Subject</p>
<p class="" id="ae9be385-b051-42d4-8573-4d2e50a95f53">Renal, Urinary
                                                    Systems &amp; Electrolytes</p>
<p class="" id="be345140-4151-4788-a59a-8377ad4831c3">System</p>
<p class="" id="a6497836-09ab-48d2-871c-a825d2357df4">Hypercalcemia</p>
<p class="" id="6510669f-4d1b-4f75-a596-3dc1440cd20d">Topic</p>
<p class="" id="7a4023ec-72ee-44b5-ab8e-10b0bf708e41">Copyright ¬©
                                                    UWorld. All rights reserved.</p>
<p class="" id="8a74b84d-cbc4-47f4-bc17-cd6b81f4fcc4">‚ùåelementFinder:
                                                    //a[@href='javascript:void(0)']</p>
</details>
</li>
</ul>
</details>


















<style>
.bionic-reading-btn {
    display: inline-flex;
    align-items: center;
    justify-content: center;
    width: 40px;
    height: 40px;
    background: rgba(255, 255, 255, 0.2);
    border: 2px solid rgba(255, 255, 255, 0.3);
    border-radius: 8px;
    color: white;
    font-size: 20px;
    cursor: pointer;
    transition: all 0.3s;
    margin-left: auto;
    flex-shrink: 0;
}

.bionic-reading-btn:hover {
    background: rgba(255, 255, 255, 0.35);
    border-color: rgba(255, 255, 255, 0.5);
    transform: scale(1.1);
}

.bionic-reading-btn.active {
    background: rgba(52, 168, 83, 0.4);
    border-color: rgba(52, 168, 83, 0.6);
}

.bionic-reading-btn.active:hover {
    background: rgba(52, 168, 83, 0.5);
}

summary {
    display: flex !important;
    align-items: center !important;
    gap: 12px !important;
}

    /* Highlighter styles */
    .highlighted {
        background-color: #ffeb3b !important;
        transition: background-color 0.2s ease !important;
    }

    .highlighter-btn {
        background: none !important;
        border: none !important;
        cursor: pointer !important;
        font-size: 20px !important;
        padding: 0 8px !important;
        margin-left: 8px !important;
        transition: transform 0.2s ease !important;
        vertical-align: middle !important;
    }

    .highlighter-btn:hover {
        transform: scale(1.2) !important;
    }

    .highlighter-btn.active {
        transform: scale(1.1) !important;
        filter: brightness(1.2) !important;
    }

    .highlighter-mode-active {
        cursor: text !important;
    }


    /* Right padding to avoid overlap with sidebar buttons */
    body {
        padding-right: 50px !important;
    }

    @media (max-width: 768px) {
        body {
            padding-right: 16px !important;
        }
    }

</style>



<script>
let bionicEnabled = false;
const originalContent = {};

function toggleBionicReading(event) {
    if (event) {
        event.preventDefault();
        event.stopPropagation();
    }

    bionicEnabled = !bionicEnabled;
    const btn = document.querySelector('.bionic-reading-btn');
    const icon = document.getElementById('bionicIcon');

    if (bionicEnabled) {
        btn.classList.add('active');
        icon.textContent = '‚úÖ';
        applyBionicReading();
    } else {
        btn.classList.remove('active');
        icon.textContent = 'üëÅÔ∏è';
        restoreOriginalText();
    }
}

function applyBionicReading() {
    // Seleciona todos os elementos de texto, EXCETO summary e buttons
    const textElements = document.querySelectorAll('p:not(summary p):not(button p), td:not(summary td):not(button td), li:not(summary li):not(button li)');

    textElements.forEach((element, index) => {
        // Ignora elementos que cont√™m outros elementos complexos
        if (element.querySelector('p, td, li, h1, h2, h3, h4, h5, h6, button, summary')) {
            return;
        }

        // Ignora se o elemento est√° dentro de um summary ou button
        if (element.closest('summary') || element.closest('button') || element.closest('.bionic-reading-btn')) {
            return;
        }

        // Salva o conte√∫do original
        if (!originalContent[index]) {
            originalContent[index] = {
                element: element,
                html: element.innerHTML
            };
        }

        // Aplica Bionic Reading
        const bionicText = convertToBionic(element.textContent);
        element.innerHTML = bionicText;
    });
}

function restoreOriginalText() {
    // Restaura o conte√∫do original
    Object.values(originalContent).forEach(item => {
        item.element.innerHTML = item.html;
    });
}

function convertToBionic(text) {
    // Divide o texto em palavras, mantendo pontua√ß√£o
    const words = text.split(/(\s+|[.,;:!?()""''\-‚Äì‚Äî])/);

    const bionicWords = words.map(word => {
        // Ignora espa√ßos e pontua√ß√£o
        if (word.match(/^\s+$/) || word.match(/^[.,;:!?()""''\-‚Äì‚Äî]+$/)) {
            return word;
        }

        // Ignora palavras muito curtas (1-2 letras)
        if (word.length <= 2) {
            return word;
        }

        // Determina quantas letras deixar em negrito (metade da palavra, arredondado para cima)
        const boldLength = Math.ceil(word.length / 2);

        // Separa a parte em negrito da parte normal
        const boldPart = word.substring(0, boldLength);
        const normalPart = word.substring(boldLength);

        // Retorna com a primeira parte em negrito
        return `<strong style="font-weight: 700 !important; color: inherit !important; background: none !important; padding: 0 !important;">${boldPart}</strong>${normalPart}`;
    });

    return bionicWords.join('');
}

// Adiciona atalho de teclado (Ctrl+B ou Cmd+B)
document.addEventListener('keydown', function(e) {
    if ((e.ctrlKey || e.metaKey) && e.key === 'b') {
        e.preventDefault();
        toggleBionicReading();
    }
});
</script>

<script>
    let highlighterActive = false;
    let questionHighlights = {};

    // Get question ID from the first summary strong tag
    function getQuestionId() {
        const firstSummary = document.querySelector('summary strong');
        return firstSummary ? firstSummary.textContent.trim() : '1';
    }

    // Load highlights from localStorage
    function loadHighlights() {
        const questionId = getQuestionId();
        const stored = localStorage.getItem('highlights_' + questionId);
        if (stored) {
            questionHighlights = JSON.parse(stored);
            applyStoredHighlights();
        }
    }

    // Save highlights to localStorage
    function saveHighlights() {
        const questionId = getQuestionId();
        localStorage.setItem('highlights_' + questionId, JSON.stringify(questionHighlights));
    }

    // Apply stored highlights
    function applyStoredHighlights() {
        Object.keys(questionHighlights).forEach(key => {
            const element = document.querySelector(`[data-highlight-id="${key}"]`);
            if (element && questionHighlights[key]) {
                element.classList.add('highlighted');
            }
        });
    }

    // Toggle highlighter mode
    function toggleHighlighter(event) {
        event.stopPropagation();
        highlighterActive = !highlighterActive;

        const btn = event.target.closest('.highlighter-btn');
        const icon = btn.querySelector('#highlighterIcon');

        if (highlighterActive) {
            btn.classList.add('active');
            icon.textContent = 'üñçÔ∏è';
            document.body.classList.add('highlighter-mode-active');
        } else {
            btn.classList.remove('active');
            icon.textContent = 'üñäÔ∏è';
            document.body.classList.remove('highlighter-mode-active');
        }
    }

    // Clear all highlights for this question
    function clearHighlights() {
        const questionId = getQuestionId();
        questionHighlights = {};
        localStorage.removeItem('highlights_' + questionId);
        document.querySelectorAll('.highlighted').forEach(el => {
            el.classList.remove('highlighted');
        });
    }

    // Handle text selection and highlighting
    document.addEventListener('mouseup', function(e) {
        if (!highlighterActive) return;

        const selection = window.getSelection();
        if (!selection.toString().trim()) return;

        const range = selection.getRangeAt(0);
        const container = range.commonAncestorContainer;

        // Only highlight text in paragraphs, not in buttons or other elements
        const paragraph = container.nodeType === 3 ? container.parentElement : container;
        if (paragraph.tagName !== 'P' && paragraph.tagName !== 'LI' && paragraph.tagName !== 'TD') {
            return;
        }

        // Create highlight span
        const span = document.createElement('span');
        span.classList.add('highlighted');

        // Generate unique ID for this highlight
        const highlightId = 'hl-' + Date.now() + '-' + Math.random().toString(36).substr(2, 9);
        span.setAttribute('data-highlight-id', highlightId);

        try {
            range.surroundContents(span);
            questionHighlights[highlightId] = true;
            saveHighlights();
        } catch (e) {
            console.log('Could not highlight selection');
        }

        selection.removeAllRanges();
    });

    // Load highlights when page loads
    window.addEventListener('load', loadHighlights);

    // Keyboard shortcut: Ctrl+H to toggle highlighter
    document.addEventListener('keydown', function(e) {
        if (e.ctrlKey && e.key === 'h') {
            e.preventDefault();
            const btn = document.querySelector('.highlighter-btn');
            if (btn) {
                toggleHighlighter({target: btn, stopPropagation: () => {}});
            }
        }
        // Ctrl+Shift+H to clear all highlights
        if (e.ctrlKey && e.shiftKey && e.key === 'H') {
            e.preventDefault();
            if (confirm('Clear all highlights for this question?')) {
                clearHighlights();
            }
        }
    });
</script>
